You are here

Article info

Article menu
Oncolytic and local immunotherapy
Original research
Systemic cellular viroimmunotherapy for canine high-grade gliomas

Authors

  • Ana Cloquell Servicio de Neurología, Hospital Clínico Veterinario, Universidad Alfonso X el Sabio, Villanueva de la Cañada, Spain PubMed articlesGoogle scholar articles
  • Isidro Mateo Servicio de Neurología, Hospital Clínico Veterinario, Universidad Alfonso X el Sabio, Villanueva de la Cañada, SpainServicio de Neurología, Hospital Veterinario VETSIA, Leganés, Spain PubMed articlesGoogle scholar articles
  • Stefano Gambera Unidad de Biotecnología Celular, Instituto de Salud Carlos III, Madrid, SpainMolecular Genetics of Angiogenesis Group, Spanish National Centre for Cardiovascular Research (CNIC), Madrid, Spain PubMed articlesGoogle scholar articles
  • Martí Pumarola Unitat de Patologia Murina i Comparada (UPMiC), Departament de Medicina i Cirurgia Animals, Facultat de Veterinaria, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Universitat Autònoma de Barcelona, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Ramon Alemany IDIBELL, Institut Català d'Oncologia, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Javier García-Castro Unidad de Biotecnología Celular, Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Ana Judith Perisé-Barrios Unidad de Investigación Biomédica (UIB-UAX), Universidad Alfonso X el Sabio, Villanueva de la Cañada, Spain PubMed articlesGoogle scholar articles

Citation

Cloquell A, Mateo I, Gambera S, et al
Systemic cellular viroimmunotherapy for canine high-grade gliomas
Journal for ImmunoTherapy of Cancer 2022;10:e005669. doi: 10.1136/jitc-2022-005669
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.